Cargando…
Prognostic value, clinical effectiveness and cost-effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events
BACKGROUND: In a substantial portion of patients (= 25%) with coronary heart disease (CHD), a myocardial infarction or sudden cardiac death without prior symptoms is the first manifestation of disease. The use of new risk predictors for CHD such as the high-sensitivity C-reactive Protein (hs-CRP) in...
Autores principales: | Schnell-Inderst, Petra, Schwarzer, Ruth, Göhler, Alexander, Grandi, Norma, Grabein, Kristin, Stollenwerk, Björn, Klauß, Volker, Wasem, Jürgen, Siebert, Uwe |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
German Medical Science GMS Publishing House
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011282/ https://www.ncbi.nlm.nih.gov/pubmed/21289893 http://dx.doi.org/10.3205/hta000068 |
Ejemplares similares
-
Extracorporal hemodialysis with acute or decompensated chronical hepatic failure
por: Hessel, Franz, et al.
Publicado: (2006) -
Individual health services
por: Schnell-Inderst, Petra, et al.
Publicado: (2011) -
Measurement of fractional flow reserve to guide decisions for percutaneous coronary intervention
por: Siebert, Uwe, et al.
Publicado: (2008) -
Antioxidative vitamines for prevention of cardiovascular disease for patients after renal transplantation and patients with chronic renal failure
por: Schnell-Inderst, Petra, et al.
Publicado: (2006) -
Comparing the clinical effectiveness of different new-born hearing screening strategies. A decision analysis
por: Grill, Eva, et al.
Publicado: (2005)